Skip to main content

Table 2 List of candidate targets of hERα.

From: Relationship between estrogen receptor α location and gene induction reveals the importance of downstream sites and cofactors

Gene symbol

EREs

FOX

SP1

Association to ESR1

AFF3

1

1

0

Not yet reported

ANXA9

1

0

1

Not yet reported

ARL3

1

1

0

Not yet reported

ARSG

0

0

0

Estrogen signaling

ATRNL1

0

1

0

Not yet reported

C6orf97

1

1

0

Upstream of ESR1, no association reported

CELSR1

2

0

0

Cancer signature

CISH

1

0

0

Known target of ESR1

CXXC5

3

2

1

Not yet reported

CYP24A1

0

0

0

Breast cancer signature

DSCAM

2

3

0

Known target of ESR1

ERBB4

1

2

0

Estrogen signaling

FAM63A

1

0

1

Not yet reported

FSIP1

1

1

0

Not yet reported

GREB1

1

0

1

Known target of ESR1

IGF1R

1

2

0

Known target of ESR1

JMJD2B

2

1

1

Known target of ESR1

LMBR1

1

1

0

Anterior upper body development

MLPH

2

2

1

Anterior upper body development

MYB

1

1

0

Known target of ESR1

PARD6B

0

1

0

Known target of ESR1

PDZK1

2

3

0

Known target of ESR1

PKIB

2

2

0

Not yet reported

PREX1

2

1

0

Cancer signature

PTPRG

2

4

0

Known target of ESR1

RARA

1

0

0

Known target of ESR1

SFXN2

1

1

0

Not yet reported

SGK3

1

1

1

Cancer signature

SIAH2

2

2

0

Known target of ESR1

SLC22A5

1

1

0

Cancer signature

SLC9A3R1

3

1

0

Cancer signature

SPOCK1

1

1

0

Cancer signature

STARD10

1

1

0

Breast cancer signature

TFF1

1

1

1

Known target of ESR1

VAV3

2

3

0

Estrogen signaling

  1. Each selected target shows at least two high stringency ChIP-chip sites and one ChIP-pet site along its transcript. In addition it scores in the 10% highest ranks in the combined rank list (cf. Fig. 5).
  2. Column 1: Gene symbol. (UCSC genome browser, hg18).
  3. Column 2–4: Number of binding motifs for hERα (EREs), FOX and SP1 respectively. EREs and FOX motifs are counted along the entire transcript, SP1 motifs are counted in ± 5 kbp of the TSS.
  4. Column 5: Brief annotation of the known association of the target to estrogen activity, or to cancer. Breast cancer signature and cancer signature reflect upregulation of the corresponding transcript in one of the reported conditions.